Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1978 Sep;14(3):403–407. doi: 10.1128/aac.14.3.403

Pharmacokinetics of Netilmicin in Patients with Renal Impairment and in Patients on Dialysis

Friedrich C Luft 1, David R Brannon 1, Linda L Stropes 1, Robert J Costello 1, Rebecca S Sloan 1, Douglas R Maxwell 1
PMCID: PMC352472  PMID: 708018

Abstract

The pharmacokinetics of netilmicin were examined in 25 adult subjects, 7 normal subjects, and 18 patients with renal impairment. Five were dialysis patients who were studied on and off dialysis. Netilmicin, 2 mg/kg, was infused intravenously over 1 h. The peak serum concentration ranged from 9 to 11 μg/ml. The mean biological half-life of netilmicin for subjects with a creatinine clearance (Ccr) > 70 ml/min was 2.7 h, for those with Ccr > 25 < 70 ml/min it was 10 h, for those with Ccr > 4 < 25 ml/min it was 32 h, and for those who were anephric it was 42 h. Ccr was correlated positively with the elimination constant and the drug's serum clearance. It was negatively correlated with the drug's volume of distribution. The dialyzer clearance of netilmicin was positively correlated with plasma flow rate and was similar to values previously reported for gentamicin. Netilmicin behaves in a fashion similar to other aminoglycosides. Therapeutic guidelines are suggested.

Full text

PDF
405

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alcid D. V., Seligman S. J. Simplified assay for gentamicin in the presence of other antibiotics. Antimicrob Agents Chemother. 1973 May;3(5):559–561. doi: 10.1128/aac.3.5.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bechtol L. D., Black H. R. Tobramycin in renal impairment. Am J Med Sci. 1975 May-Jun;269(3):317–321. doi: 10.1097/00000441-197505000-00004. [DOI] [PubMed] [Google Scholar]
  3. Bennett W. M., Hartnett M. N., Craven R., Gilbert D. N., Porter G. A. Gentamicin concentrations in blood, urine, and renal tissue of patients with end-stage renal disease. J Lab Clin Med. 1977 Aug;90(2):389–393. [PubMed] [Google Scholar]
  4. Gordon R. C., Regamey C., Kirby W. M. Serum protein binding of the aminoglycoside antibiotics. Antimicrob Agents Chemother. 1972 Sep;2(3):214–216. doi: 10.1128/aac.2.3.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gyselynck A. M., Forrey A., Cutler R. Pharmacokinetics of gentamicin: distribution and plasma and renal clearance. J Infect Dis. 1971 Dec;124 (Suppl):S70–S76. doi: 10.1093/infdis/124.supplement_1.s70. [DOI] [PubMed] [Google Scholar]
  6. Halpren B. A., Axline S. G., Coplon N. S., Brown D. M. Clearance of gentamicin during hemodialysis: comparison of four artificial kidneys. J Infect Dis. 1976 Jun;133(6):627–636. doi: 10.1093/infdis/133.6.627. [DOI] [PubMed] [Google Scholar]
  7. Kooijman J. M. Evaluation of the mass-transfer process in artificial kidneys. Neth J Med. 1973;16(3):121–128. [PubMed] [Google Scholar]
  8. Luft F. C., Yum M. N., Kleit S. A. Comparative nephrotoxicities of netilmicin and gentamicin in rats. Antimicrob Agents Chemother. 1976 Nov;10(5):845–849. doi: 10.1128/aac.10.5.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Meyers B. R., Hirschman S. Z. Antimicrobial activity in vitro of netilmicin and comparison with sisomicin, gentamicin, and tobramycin. Antimicrob Agents Chemother. 1977 Jan;11(1):118–121. doi: 10.1128/aac.11.1.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Miller G. H., Arcieri G., Weinstein M. J., Waitz J. A. Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic. Antimicrob Agents Chemother. 1976 Nov;10(5):827–836. doi: 10.1128/aac.10.5.827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nedden R., Fuchs T., Schröder K., Wundt W. Die renale Ausscheidung von Gentamicin beim Menschen. Dtsch Med Wochenschr. 1972 Oct 6;97(40):1496–passim. doi: 10.1055/s-0028-1107589. [DOI] [PubMed] [Google Scholar]
  12. Pechère J. C., Pechère M. M., Dugal R. Clinical pharmacokinetics of sisomicin: dosage schedules in renal-impaired patients. Antimicrob Agents Chemother. 1976 May;9(5):761–765. doi: 10.1128/aac.9.5.761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Plantier J., Forrey A. W., O'Neill M. A., Blair A. D., Christopher T. G., Cutler R. E. Pharmacokinetics of amikacin in patients with normal or impaired renal function: radioenzymatic acetylation assay. J Infect Dis. 1976 Nov;134(Suppl):S323–S330. doi: 10.1093/infdis/135.supplement_2.s323. [DOI] [PubMed] [Google Scholar]
  14. Rahal J. J., Jr, Simberkoff M. S., Kagan K., Moldover N. H. Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms. Antimicrob Agents Chemother. 1976 Apr;9(4):595–599. doi: 10.1128/aac.9.4.595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Regamey C., Gordon R. C., Kirby W. M. Comparative pharmacokinetics of tobramycin and gentamicin. Clin Pharmacol Ther. 1973 May-Jun;14(3):396–403. doi: 10.1002/cpt1973143396. [DOI] [PubMed] [Google Scholar]
  16. Schentag J. J., Lasezkay G., Cumbo T. J., Plaut M. E., Jusko W. J. Accumulation pharmacokinetics of tobramycin. Antimicrob Agents Chemother. 1978 Apr;13(4):649–656. doi: 10.1128/aac.13.4.649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Welling P. G., Baumueller A., Lau C. C., Madsen P. O. Netilmicin pharmacokinetics after single intravenous doses to elderly male patients. Antimicrob Agents Chemother. 1977 Sep;12(3):328–334. doi: 10.1128/aac.12.3.328. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES